Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Luger

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Bone Marrow Transplantation|March 15, 2016
Allogeneic transplant for FLT3-ITD+ AML: room for improvementA E Perl, S M Luger
Bone Marrow Transplantation|April 25, 2006
Autologous stem cell transplant in ALL: who should we be transplanting in first remission?A R Mato, S M Luger
Blood|August 15, 1996
Bone marrow purging with oligodeoxynucleotidesA M Gewirtz, S M Luger, E Stadtmauer
International Journal of Cell Cloning|July 1, 1992
The c-kit proto-oncogene in normal and malignant human hematopoiesisM Z Ratajczak, S M Luger, A M Gewirtz
Journal of Bacteriology|May 1, 1986
Role of ribosome degradation in the death of starved Escherichia coli cellsB D Davis, S M Luger, P C Tai
Journal of the National Cancer Institute|December 19, 1990
High-dose cisplatin and dacarbazine in the treatment of metastatic melanomaS M Luger, J M Kirkwood, M S Ernstoff, et al.
The Journal of Biological Chemistry|June 2, 1995
Vav is necessary for prolactin-stimulated proliferation and is translocated into the nucleus of a T-cell lineC V Clevenger, W Ngo, D L Sokol, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1992
Role of the KIT protooncogene in normal and malignant human hematopoiesisM Z Ratajczak, S M Luger, K DeRiel, et al.
Blood|April 15, 1992
Acute- and chronic-phase chronic myelogenous leukemia colony-forming units are highly sensitive to the growth inhibitory effects of c-myb antisense oligodeoxynucleotidesM Z Ratajczak, N Hijiya, L Catani, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 1992
In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotidesM Z Ratajczak, J A Kant, S M Luger, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Bone Marrow Transplantation|March 15, 2016
Allogeneic transplant for FLT3-ITD+ AML: room for improvementA E Perl, S M Luger
Bone Marrow Transplantation|April 25, 2006
Autologous stem cell transplant in ALL: who should we be transplanting in first remission?A R Mato, S M Luger
Blood|August 15, 1996
Bone marrow purging with oligodeoxynucleotidesA M Gewirtz, S M Luger, E Stadtmauer
International Journal of Cell Cloning|July 1, 1992
The c-kit proto-oncogene in normal and malignant human hematopoiesisM Z Ratajczak, S M Luger, A M Gewirtz
Journal of Bacteriology|May 1, 1986
Role of ribosome degradation in the death of starved Escherichia coli cellsB D Davis, S M Luger, P C Tai
Journal of the National Cancer Institute|December 19, 1990
High-dose cisplatin and dacarbazine in the treatment of metastatic melanomaS M Luger, J M Kirkwood, M S Ernstoff, et al.
The Journal of Biological Chemistry|June 2, 1995
Vav is necessary for prolactin-stimulated proliferation and is translocated into the nucleus of a T-cell lineC V Clevenger, W Ngo, D L Sokol, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1992
Role of the KIT protooncogene in normal and malignant human hematopoiesisM Z Ratajczak, S M Luger, K DeRiel, et al.
Blood|April 15, 1992
Acute- and chronic-phase chronic myelogenous leukemia colony-forming units are highly sensitive to the growth inhibitory effects of c-myb antisense oligodeoxynucleotidesM Z Ratajczak, N Hijiya, L Catani, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 1992
In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotidesM Z Ratajczak, J A Kant, S M Luger, et al.
Pageof 4